论文部分内容阅读
目的探讨盐酸氨溴索联合左氧氟沙星和痰热清联合先锋Ⅵ两组药物对慢性支气管炎急性发作的疗效。方法选用本院2011年1月至2013年12月期间收治的慢性支气管炎病例80例,随机分为A、B两组,A组采用盐酸氨溴索联合左氧氟沙星治疗,B组采用痰热清联合先锋Ⅵ治疗,对患者进行为期10 d的治疗后,比较两组患者疗效情况。结果经过对慢性支气管炎急性发作患者进行为期10 d的治疗,两组经治疗前、后血常规中中性粒细胞百分比都有明显性差异,在疗效标准上盐酸氨溴索联合左氧氟沙星治疗优于痰热清联合先锋Ⅵ治疗。结论盐酸氨溴索联合左氧氟沙星是治疗慢性支气管炎急性发作的一种有效的治疗方法,该方法具有临床疗效确切及不良反应少且轻微的特点。
Objective To investigate the efficacy of combination of ambroxol hydrochloride combined with levofloxacin and Tanreqing combined with Pioneer Ⅵ in the treatment of acute exacerbation of chronic bronchitis. Methods Eighty patients with chronic bronchitis admitted from January 2011 to December 2013 in our hospital were randomly divided into A and B groups. A group was treated with ambroxol hydrochloride combined with levofloxacin, B group was treated with combination of phlegm and heat Pioneer Ⅵ treatment, the patients were treated for 10 days, compared the efficacy of two groups of patients. Results After the treatment of acute exacerbation of chronic bronchitis for 10 days, the percentages of neutrophils in the blood routine before and after treatment in both groups were significantly different. Ambroxol hydrochloride combined with levofloxacin was superior to the standard Tanreqing combined Pioneer Ⅵ treatment. Conclusion Ambroxol hydrochloride combined with levofloxacin is an effective treatment for the treatment of acute exacerbation of chronic bronchitis. The method has the characteristics of definite curative effect and few and mild adverse reactions.